Innovative Medicines & Omics (IMO) is a peer-reviewed and open-access journal that publishes high-quality articles related to the discovery and development of innovative medicines through omics research in the field of human and animal health, for all the major therapeutic areas.

The journal includes a variety of omics layers, such as genomics, proteomics, epigenomics metabolomics, lipidomics, peptidomics, metagenomics, microbiome, pharmacogenomics, toxicogenomics, etc., with the focus on disease etiology, prevention, treatment, prognosis and monitoring.

Features include original research articles, reviews, short communications and editorials. Topics of particular interest include, but are not limited to:

• Disease evolution and heterogeneity
• Single-cell sequencing technique
• Circulating tumor cell
• Personalized medicine
• Drug sensitivity screening
• Combination therapy
• Drug resistance
• Disease therapeutic mechanism and marker detection
• Database and web server
• Computational method
• Assisted reproduction
• Embryonic development
• Animal organ regeneration
• Bioproduct and biomaterial
• Novel therapeutic strategies
• High-throughput screening
• Therapeutic targets
• Combinatorial chemistry, parallel synthesis and library design
• Drug delivery
• Advances in key compound classes and therapeutic areas
• Automation and technology